This is a prospective, multicenter real-world study to describe the postoperative outcomes and quality of life, disease control and characteristics of patients who underwent surgery, as well as economic burden and post-operative treatment patterns in Chinese patients with CRSwNP recurrence.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
• The observed and change from baseline of Sino-Nasal Outcome Test (SNOT)-22 score at week-52
Timeframe: week0-52
• The observed and change from baseline of Modified Lund-Kennedy (MLK) score at week-52
Timeframe: week0-52
AstraZeneca Clinical Study Information Center